Other genes, including MYB proto-oncogene like 2 (MYBL2), cyclin dependent kinase inhibitor 2A (CDKN2A), and stathmin 3 (STMN3) were significantly upregulated in tumor tissues from CRC patients and were significantly associated with specific bacterial genera (Figure 4B). Here, CDKN2A is linked to colorectal carcinoma.